Pharmaceutical Industry Pharmacovigilance & Drug Safety
Published 10/2023
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz
Language: English | Size: 2.61 GB | Duration: 2h 13m
Published 10/2023
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz
Language: English | Size: 2.61 GB | Duration: 2h 13m
Pharmacovigilance & Drug Safety: Unlocking the Secrets to Ensuring Medication Safety Worldwide
What you'll learn
Introduction to Pharmacovigilance: Understanding the importance and objectives of pharmacovigilance in ensuring drug safety.
Historical Perspective: Incidents that led to the evolution and development of pharmacovigilance.
Regulatory Framework: An overview of global pharmacovigilance regulations and guidelines, including those by the World Health Organization (WHO) and the Interna
Adverse Drug Reactions (ADR) Reporting: The process and significance of reporting ADRs, understanding spontaneous reports.
Signal Detection: Methods and tools used in signal detection and the significance of identifying new safety concerns.
Risk Management: Strategies and tools used in assessing and minimizing risks associated with drug use.
Post-Marketing Surveillance: Strategies used to monitor the safety of a drug after it has been approved and is in the market.
Requirements
There Are No Requirements Necessary To Enroll. I Only Ask To Come Open-Minded And Ready To Learn.
Description
Pharmacovigilance, the science of detecting, assessing, understanding, and preventing adverse effects or any drug-related problem, is a cornerstone of patient safety. This comprehensive course offers a deep dive into the world of drug safety, ensuring that healthcare professionals, researchers, and stakeholders are equipped with the latest knowledge and best practices.Key Learning Outcomes:Foundations of Pharmacovigilance: Traverse the history and significance of pharmacovigilance, understanding its pivotal role in global health.Regulatory Landscape: Explore the international guidelines, regulations, and authorities that shape drug safety surveillance.Adverse Drug Reactions (ADR) and Reporting: Gain insights into the identification, documentation, and reporting of ADRs, enhancing patient safety.Signal Detection & Risk Management: Master the tools and techniques for signal detection and develop strategies to assess and mitigate drug risks.Real-world Pharmacovigilance: Delve into post-marketing surveillance, patient support programs, and the role of big data in monitoring drug safety.Ethics & Challenges: Address the ethical considerations in pharmacovigilance and explore the dynamic challenges and future prospects of the field.Whether you're a healthcare professional aiming to enhance patient safety, a researcher keen on understanding drug effects in populations, or simply a curious learner, this course will equip you with the expertise to navigate the intricate and ever-evolving world of pharmacovigilance. Join us on this enlightening journey and be at the forefront of global medication safety.
Overview
Section 1: Introduction to Pharmacovigilance and Drug Safety
Lecture 1 Introduction
Lecture 2 Partners in Pharmacovigilance and Drug Safety Monitoring
Lecture 3 National Pharmacovigilance Centers Role in ADRs Reporting
Section 2: Good Pharmacovigilance Practices
Lecture 4 Introduction and Principles
Lecture 5 Pharmacovigilance Quality Management Systems
Lecture 6 Significances and impacts of Pharmacovigilance Quality Management Systems
Lecture 7 Pharmacovigilance System Master File and Pharmacovigilance Inspections
Lecture 8 Pharmacovigilance Audit and Risk Management
Lecture 9 Collection, Management and Submission of Report
Lecture 10 Periodic Safety Update Report
Lecture 11 Post-Authorization Safety Study
Lecture 12 Signal Management and Additional Monitoring
Lecture 13 Safety Communication
Lecture 14 Risk Minimization Measures
Section 3: Signals
Lecture 15 Signals and Signals Identification
Lecture 16 Methods of Signals Identification
Lecture 17 Strengthening the Signal
Lecture 18 Pharmacovigilance Indicators
Lecture 19 Relationships and Causality Assessment
Lecture 20 WHO-UMC Causality Assessment System
Lecture 21 Algorithmic Methods for Causality Assessment
Section 4: Pharmacovigilance Surveillance and Methods
Lecture 22 Pharmacovigilance Surveillance and Methods Used for Drug Safety Monitoring
Lecture 23 Spontaneous Reporting
Lecture 24 WHO Criteria for Spontaneous Reporting
Lecture 25 Cohort Event Monitoring (Part 1)
Lecture 26 Cohort Event Monitoring (Part 2)
Lecture 27 Difference between Cohort Event Monitoring and Spontaneous Reporting
Lecture 28 Drug Safety Monitoring - Developing a Consumer Reporting System
Lecture 29 Drug Safety Monitoring: Components of a Report And the Method of Reporting
Section 5: Risk Management
Lecture 30 Risk Factors
Lecture 31 Premarket Benefit-Risk Assessment
Lecture 32 Postmarket Benefit-Risk Assessment
The Ideal Student For This Course Is Anyone Who Wants To Learn About 'Pharmacovigilance' Or An Existing Professional Who Wants To Expand On Their Current Skills.

